enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Why Is Regeneron Pharmaceuticals Stock Trading Lower Today? - AOL

    www.aol.com/why-regeneron-pharmaceuticals-stock...

    On Thursday, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported third-quarter adjusted EPS of $12.46, up 8% year-over-year, beating the consensus of $11.69. The company reported sales of $3.72 ...

  3. What's Going On With Regeneron Pharmaceuticals Stock On ... - AOL

    www.aol.com/finance/whats-going-regeneron...

    On Friday, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion recommending ...

  4. Regeneron Beats EPS and Revenue Estimates - AOL

    www.aol.com/regeneron-beats-eps-revenue...

    Regeneron's COVID-19 drug sales drove revenue and EPS.

  5. Regeneron stock surges on positive results in eye disease ...

    www.aol.com/news/regeneron-stock-surges-positive...

    Yahoo Finance Live examines Regeneron Pharmaceuticals' stock following reports of positive results in its eye treatment drug trials.

  6. Top Stock Reports for Oracle, Intuit & Regeneron ... - AOL

    www.aol.com/news/top-stock-reports-oracle-intuit...

    Top Stock Reports for Oracle, Intuit & Regeneron Pharmaceuticals

  7. Regeneron beats quarterly results on strong demand for ... - AOL

    www.aol.com/news/regeneron-beats-quarterly...

    Regeneron reported an adjusted profit of $11.56 per share on total revenue of $3.55 billion for the quarter, above analysts' estimates of $10.61 per share and $3.38 billion, according to LSEG data.

  8. Regeneron (REGN) Earnings Expected to Grow: What to ... - AOL

    www.aol.com/news/regeneron-regn-earnings...

    Regeneron (REGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  9. Why Regeneron Pharmaceuticals (REGN) Isn't Done Growing ... - AOL

    www.aol.com/news/why-regeneron-pharmaceuticals...

    For premium support please call: 800-290-4726 more ways to reach us